Science & Research

FDA Grand Rounds

Image of scientist holding test tube


The FDA Grand Rounds is webcast every other month to highlight cutting-edge research underway across the Agency and its impact on protecting and advancing public health. Each session features an FDA scientist presenting on a key public health challenge and how FDA is applying science to its regulatory activities. The 45-minute presentation is followed by questions from the audience.

Past Grand Rounds

Thursday, May 12, 2016
12:00 to 1:00 p.m.
 

Lecture on Webcast:

Antibiotic resistance surveillance in the age of genomics: New answers to old questions.  

Presented by:

Patrick F. McDermott, MS, PhD
Principal Investigator
FDA Center for Veterinary Medicine

About the Presentation

Antibiotic resistance is a negative consequence of antibiotic use that directly threatens the efficacy of an important class of FDA-regulated drugs. Resistance is a unique challenge because it can spread and affect treatment outcomes in other members of the community.The use of antibiotics in animal agriculture can lead to foodborne transmission of resistant bacteria to humans. To monitor resistance in these bacteria from retail meats, food-producing animals, and human clinical cases of infection, FDA, USDA, and CDC launched an interagency collaborative effort in 1996 called the National Antimicrobial Resistance Monitoring System (NARMS). 

The advent of whole genome sequencing technology has revolutionized the type of surveillance that NARMS performs. The availability of comprehensive genetic data is revealing new features of the resistant foodborne bacteria that cause human illness. This knowledge, in turn, is strengthening the scientific basis on which sound regulatory decisions are made. 

About the Presenter

Dr. Patrick McDermott is Director of NARMS, a position he has held since 2008. He is past Deputy Director of the Office of Research at FDA’s Center for Veterinary Medicine. A Microbiologist by training, he has 25 years of experience researching antimicrobial resistance. He represents FDA as a member of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) and on the Steering Committee of the WHO Global Foodborne Infections Network (GFN). Dr. McDermott is a member of the Interagency and Transatlantic Task Forces on Antimicrobial Resistance.

Past Grand Rounds

 

Page Last Updated: 05/13/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.